Dr. Hahn discusses what key counseling points a community pharmacist can utilize to allay the fears of potential addiction to their pain patient using chronic opioid therapy.

Dr. Nicholson discusses if the undertreatment of pain can result in pseudoaddiction and defines pseudoaddiction.

Dr. Kirsh discusses what key factors should be included in a treatment agreement.

Dr. Strassels discusses how we can best assess the contributions that community-based pharmacists make to patient outcomes and if there is data to support this.